These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4296291)

  • 1. Antibody to rhinovirus in human sera. II. Heterotypic responses.
    Fleet WF; Douglas RG; Cate TR; Couch RB
    Proc Soc Exp Biol Med; 1968 Feb; 127(2):503-9. PubMed ID: 4296291
    [No Abstract]   [Full Text] [Related]  

  • 2. The sedimentation behavior of rhinovirus neutralizing activity in nasal secretion and serum following the rhinovirus common cold.
    Rossen RD; Douglas G; Cate TR; Couch RB; Butler WT
    J Immunol; 1966 Oct; 97(4):532-8. PubMed ID: 4289223
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemagglutination-inhibition test in rhinovirus infections of volunteers.
    Reed SE; Hall TS
    Infect Immun; 1973 Jul; 8(1):1-3. PubMed ID: 4352454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhinovirus neutralizing antibody in tears, parotid saliva, nasal secretions and serum.
    Douglas RG; Rossen RD; Butler WT; Couch RB
    J Immunol; 1967 Aug; 99(2):297-303. PubMed ID: 4166403
    [No Abstract]   [Full Text] [Related]  

  • 5. An ELISA for the detection of rhinovirus specific antibody in serum and nasal secretion.
    Barclay WS; Al-Nakib W
    J Virol Methods; 1987 Jan; 15(1):53-64. PubMed ID: 3027117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhinovirus infections in an industrial population. IV. Infections within families of employees during two fall peaks of respiratory illness.
    Hendley JO; Gwaltney JM; Jordan WS
    Am J Epidemiol; 1969 Feb; 89(2):184-96. PubMed ID: 4303933
    [No Abstract]   [Full Text] [Related]  

  • 7. The specificity of antibodies induced by infection with rhinovirus type 2.
    Carey BS; Barclay WS; Russell SM; Tyrrell DA
    J Med Virol; 1992 Apr; 36(4):251-8. PubMed ID: 1315837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The time course of the humoral immune response to rhinovirus infection.
    Barclay WS; al-Nakib W; Higgins PG; Tyrrell DA
    Epidemiol Infect; 1989 Dec; 103(3):659-69. PubMed ID: 2558033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of rhinovirus common colds in human voluteers.
    Douglas RG
    Ann Otol Rhinol Laryngol; 1970 Jun; 79(3):563-71. PubMed ID: 4316718
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of an enzyme-linked immunosorbent assay that measures rhinovirus-specific antibodies in human sera and nasal secretions.
    Barclay WS; Callow KA; Sergeant M; al-Nakib W
    J Med Virol; 1988 Aug; 25(4):475-82. PubMed ID: 2844987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contamination of the population with rhinovirus type 1A, 1B and 7].
    Mentel R; Oberender H; Schmidt J
    Z Gesamte Hyg; 1971 Sep; 17(9):676-8. PubMed ID: 4333182
    [No Abstract]   [Full Text] [Related]  

  • 12. Attempt at immunization by oral feeding of live rhinoviruses in enteric-coated capsules.
    Mascoli CC; Leagus MB; Weigel RE; Stokes J; Reinhart H; Hilleman MR
    Proc Soc Exp Biol Med; 1966 Apr; 121(4):1264-8. PubMed ID: 4287125
    [No Abstract]   [Full Text] [Related]  

  • 13. Homologous and heterologous resistance to rhinovirus common cold.
    Fleet WF; Couch RB; Cate TR; Knight V
    Am J Epidemiol; 1965 Sep; 82(2):185-96. PubMed ID: 4283952
    [No Abstract]   [Full Text] [Related]  

  • 14. Relation between blood groups and resistance to infection with influenza and spome picornaviruses.
    Tyrrell DA; Sparrow P; Beare AS
    Nature; 1968 Nov; 220(5169):819-20. PubMed ID: 4301643
    [No Abstract]   [Full Text] [Related]  

  • 15. Leukocyte responses to experimental infection with human rhinovirus.
    Thomas LH; Fraenkel DJ; Bardin PG; Johnston SL; Holgate ST; Warner JA
    J Allergy Clin Immunol; 1994 Dec; 94(6 Pt 2):1255-62. PubMed ID: 7528234
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of illness from rhinovirus infection by a topical interferon inducer.
    Panusarn C; Stanley ED; Dirda V; Rubenis M; Jackson GG
    N Engl J Med; 1974 Jul; 291(2):57-61. PubMed ID: 4365144
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody to rhinovirus in human sera. I. Standardization of a neutralization test.
    Douglas RG; Fleet WF; Cate TR; Couch RB
    Proc Soc Exp Biol Med; 1968 Feb; 127(2):497-502. PubMed ID: 4296290
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial.
    Turner RB; Wecker MT; Pohl G; Witek TJ; McNally E; St George R; Winther B; Hayden FG
    JAMA; 1999 May; 281(19):1797-804. PubMed ID: 10340366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental rhinovirus infection in human volunteers exposed to ozone.
    Henderson FW; Dubovi EJ; Harder S; Seal E; Graham D
    Am Rev Respir Dis; 1988 May; 137(5):1124-8. PubMed ID: 2461669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of protective effect of neutralizing antibody in serum and nasal secretions in experimental rhinovirus type 13 illness.
    Perkins JC; Tucker DN; Knopf HL; Wenzel RP; Kapikian AZ; Chanock RM
    Am J Epidemiol; 1969 Dec; 90(6):519-26. PubMed ID: 4312066
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.